Correction to: Nature Communications https://doi.org/10.1038/s41467-020-20664-5, published online 18 January 2021.
The original version of this Article contained an error in Fig. 7. In Fig. 7a panels “alphaDll1” and “IMD” were inadvertently duplicated. The correct version of Fig. 7a is shown below.
The incorrect version of Fig. 7a is shown below.
The original version of this Article contained an error in the legend of Fig. 7. The sentence “The alone doxorubicin group was used for both the experiments in Fig. 7a–b and 8 d, e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)” was replaced with “The alone doxorubicin and αDll1+Dox groups were used for both the experiments in Fig. 6a–b and 7d,e (n = 6 Dox, n = 4 αDll1 ab+Dox, n = 4 αDll1 ab+IMD, n = 6 αDll1 ab+Dox+IMD tumors)”.
In the original source data file of Fig. 7b, the value for cell 4f contained a wrong number.
These errors been corrected in both the PDF and HTML versions of the Article and the source data has been replaced.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kumar, S., Nandi, A., Singh, S. et al. Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nat Commun 13, 3927 (2022). https://doi.org/10.1038/s41467-022-30946-9
Published:
DOI: https://doi.org/10.1038/s41467-022-30946-9
